文献速递骨质疏松与代谢性骨病创伤骨科关节外科

褪黑素与骨相关疾病:当前证据与未来前景的机制性综述更新

Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects.
PubMed 文献 · Osteoporos Int · 2023-07-02

本文综述了褪黑素对骨相关疾病治疗作用的体外、体内和临床证据,聚焦分子机制。检索Scopus和MEDLINE/PubMed从建库至2023年6月的文献。结果表明褪黑素对骨质疏松、骨折愈合、骨关节炎和类风湿关节炎等骨与软骨相关疾病有益,但需进一步临床研究明确其疗效。

要点

  • 褪黑素对骨质疏松、骨折愈合、骨关节炎和类风湿关节炎等骨与软骨相关疾病有益。
  • 褪黑素还具有控制睡眠和昼夜节律的作用。
  • 多种动物和临床研究表明褪黑素可能成为控制、减轻或抑制骨相关疾病的有效治疗剂。

核心结论

  • 多种动物和临床研究表明褪黑素的多种生物学效应可能使其成为控制、减轻或抑制骨相关疾病的有效治疗剂。
  • 因此,需要进一步的临床研究来明确褪黑素对骨相关疾病患者是否有效。

研究设计与样本

  • 本综述总结了关于褪黑素对骨相关疾病作用的体外、体内和临床研究证据,重点关注分子机制。
  • 通过电子检索Scopus和MEDLINE®/PubMed数据库,检索从建库至2023年6月发表的关于褪黑素和骨相关疾病的文章。

主要发现

  • 研究结果表明褪黑素对骨质疏松、骨折愈合、骨关节炎和类风湿关节炎等骨与软骨相关疾病有益。
  • 褪黑素还具有控制睡眠和昼夜节律的作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步的临床研究来明确褪黑素对骨相关疾病患者是否有效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Bone diseases account for an enormous cost burden on health systems. Bone disorders are considered as age-dependent diseases. The aging of world population has encouraged scientists to further explore the most effective preventive modalities and therapeutic strategies to overcome and reduce the high cost of bone disorders. Herein, we review the current evidence of melatonin's therapeutic effects on bone-related diseases. METHODS: This review summarized evidences from in vitro, in vivo, and clinical studies regarding the effects of melatonin on bone-related diseases, with a focus on the molecular mechanisms. Electronically, Scopus and MEDLINE®/PubMed databases were searched for articles published on melatonin and bone-related diseases from inception to June 2023. RESULTS: The findings demonstrated that melatonin has beneficial effect in bone- and cartilage-related disorders such as osteoporosis, bone fracture healing, osteoarthritis, and rheumatoid arthritis, in addition to the control of sleep and circadian rhythms. CONCLUSION: A number of animal and clinical studies have indicated that various biological effects of melatonin may suggest this molecule as an effective therapeutic agent for controlling, diminishing, or suppressing bone-related disorders. Therefore, further clinical studies are required to clarify whether melatonin can be effective in patients with bone-related diseases.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Bagherifard A, Hosseinzadeh A, Koosha F, et al. Melatonin and bone-related diseases: an updated mechanistic overview of current evidence and future prospects. Osteoporos Int. 2023. PMID: 37393580. doi:10.1007/s00198-023-06836-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。